Yarmouk University Secures U.S. Patent for Solvent-Free Dry Coating Technology in Pharmaceutical Manufacturing
核心洞察
Yarmouk University has been granted a U.S. patent for a novel dry coating system that eliminates the need for liquid solvents in solid pharmaceutical product manufacturing.
The technology modifies pneumatic flow compression equipment to reduce manufacturing time and cut operational costs by more than half, according to the researchers.
The innovation aligns with sustainability and green economy goals by removing costly organic solvents that pose environmental risks.
Yarmouk University has secured a patent from the United States Patent and Trademark Office (USPTO) for a novel pharmaceutical manufacturing technology that enables dry coating of solid pharmaceutical products without the use of liquid solvents. The patent, titled "System and Method for Dry Coating of Substrate Materials," represents a significant advancement in production efficiency and environmental sustainability, according to a university statement.
The innovation was developed through a collaborative research partnership bridging academia and industry. The team includes Dr. Dirar Al-Omari from the Faculty of Pharmacy at Yarmouk University, Dr. Sami Qasem from Tabuk Pharmaceuticals (搜索), and industrial expert Hussein Talafha of Talafha Industrial Establishment (搜索).
A Solvent-Free Manufacturing Paradigm
The patented technology introduces a modification to pneumatic flow compression equipment conventionally used in coating solid pharmaceutical products. The key breakthrough lies in enabling the coating process to operate entirely without liquid solvents — whether organic or water-based — marking what the researchers describe as an important technological shift in pharmaceutical manufacturing.
By eliminating solvent use, the system improves production efficiency, reduces manufacturing time, and cuts operational costs by more than half. The technology also removes the need for costly organic solvents that carry inherent environmental risks, directly aligning with sustainability and green economy objectives.
From Academic Research to Industrial Application
Dr. Dirar Al-Omari emphasized that the achievement demonstrates the capacity of scientific research in Jordanian universities to move beyond academic theory into practical industrial application. He noted that the patent contributes to the development of more efficient and sustainable pharmaceutical manufacturing methods, consistent with global industry trends focused on lowering costs and improving production quality.
The university stated that the patent reflects its broader strategy of promoting applied scientific research and directing innovation toward commercially viable industrial applications.
Commercialization Efforts Underway
Yarmouk University's Deanship of Scientific Research and Graduate Studies, through its Technology Transfer Department, is actively working to commercialize the patent in partnership with industrial and investment sectors. University officials indicated that the effort aims to transform research outcomes into economic value while strengthening Jordan's position in regional and international innovation ecosystems.